Hartley Medical Center Pharmacy Recalls Morphine Sulfate and Bupivacaine Syringes
Hartley Medical Center Pharmacy is recalling Morphine Sulfate and Bupivacaine syringes due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the rubric specifies that FDA Class II recalls with potential for serious injury (implied by sterility failure in injectables) or structural defects warrant a score of 4.
Plain-English summary
Hartley Medical Center Pharmacy, Incorporated is recalling Morphine Sulfate 50 mg/ml/Bupivacaine HCL 24 mg/ml, 20 ml syringes. The recall is being conducted because of a lack of assurance of sterility for the product.
The affected product is a prescription-only medication distributed nationwide. No foreign distribution is reported. The specific product code information indicates a Beyond Use Date (BUD) of 5/3/2016.
Consumers and healthcare providers should stop using the recalled syringes and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- Morphine Sulfate 50 mg/ml/Bupivacaine HCL 24 mg/ml, vol. 20 ml syringe, Rx only, Hartley Med Ctr Pharmacy, Long Beach, CA
- Manufacturer
- Hartley Medical Center Pharmacy, Incorporated
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- BUD: 5/3/2016
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Hartley Medical Center Pharmacy, Incorporated under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Hartley Medical Center Pharmacy, Incorporated
See all →- SevereHartley Medical Center Pharmacy Recalls Sufentanil Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Baclofen Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Baclofen Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-03-16
- SevereMorphine Sulfate Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2016-03-16
- SevereHartley Medical Center Pharmacy Recalls Morphine and Bupivacaine Syringes
FDA (Drugs) · 2016-03-16
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SeverePharmakon Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereSCA Pharmaceuticals Recalls Morphine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-07-11
- SevereMartin Avenue Pharmacy Recalls Compounded Hydromorphone and Bupivacaine Injections
FDA (Drugs) · 2014-11-05
- HighMartin Avenue Pharmacy Recalls Morphine Sulfate Syringes for Sterility Concerns
FDA (Drugs) · 2014-11-05
- SeverePharmakon Recalls Bupivacaine HCI Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereSCA Pharmaceuticals Recalls Hydromorphone and Bupivacaine Injection Bags
FDA (Drugs) · 2017-11-08